The average US life expectancy decreased by nearly 2 years from 2018 to 2020, with minority groups affected the most; the FDA will add a rare heart inflammation warning to fact sheets for the Pfizer and Moderna COVID-19 vaccines; a series of expansions to the Medicaid safety-net program is reportedly in consideration.
Agility has long been a big buzzword, but its salience and importance has been growing. Gallup’s research on agility finds that there are 7 fundamental shifts common to highly agile leaders—driving these changes through a hospital can help significantly advance a culture of agility.
The Biden administration shifts its planned vaccine donation from 80 million to 55 million vaccines amid ongoing safety review of AstraZeneca doses; a CMS report indicates that nearly 10 million individuals enrolled in Medicaid and CHIP amid the pandemic; significantly more deaths by suicide are reported than combat deaths in the US military.
As a specialized health care service, telemedicine was shown to be comparable to traditional care for persons living with HIV in rural Georgia.
An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.
HHS Secretary Xavier Becerra and CMS Administrator Chiquita Brooks-LaSure discussed next steps following the Supreme Court’s decision to uphold the Affordable Care Act (ACA), including continued expansion of Medicaid benefit coverage and addressing disparities in maternal mortality rates nationwide.
Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.
Eligible patients who are not waitlisted for kidney transplants lose profound opportunities and are subject to racial and socioeconomic disparities regarding waitlist placement, a study showed.
In a 7 to 2 decision, the Supreme Court ruled Thursday that the Affordable Care Act (ACA) will stand, as plaintiffs seeking to declare the law unconstitutional did not have standing.
Camille Hertzka, vice president and head of Oncology, US Medical, AstraZeneca, speaks about the real-world data collection of durvalumab to assess applicability in patients not involved in the PACIFIC trial, and the importance of diversity and inclusion in clinical trials moving forward.
About one-third of patients prefer in-hospital administration, particularly if they are older or already make frequent visits to the hospital.
On this episode of Managed Care Cast, we speak with the author of the annual PwC Behind the Numbers report, which looks ahead at medical cost trends in the United States.
Michael Thorpy, MD, director, Sleep-Wake Disorders Center, Montefiore Medical Center, and professor of neurology, Albert Einstein College of Medicine, speaks on the efficacy of solriamfetol observed in patients with excessive daytime sleepiness associated with narcolepsy, and which patient groups may best benefit from this therapy.
This article demonstrates that few patient encounters with indicators of need for diabetes self-management education result in a provider referral to the service.
The debate continues whether or not to go maskless when fully vaccinated; the Delta COVID-19 variant is associated with a 2-fold greater risk of hospitalization; an extra vaccine dose may boost COVID-19 protection in organ transplant recipients.
Anne Marie Morse, DO, pediatric neurologist and sleep medicine specialist, Geisinger, discusses factors contributing to insufficient screening of obstructive sleep apnea (OSA) in patients with stroke and how a team-based approach fared in expediting diagnosis.
Experts from around the world discussed how to best manage the clinical issues presented by patients with refractory chronic cough, who often spend years trying to find effective relief.
Isabelle Arnulf, MD, PhD, senior neurologist, and professor, Neurology, Sorbonne Universités, Pierre and Marie Curie University, discusses findings of significant improvement observed in patients with idiopathic hypersomnia undergoing lower-sodium oxybate treatment.
An overview of the latest news in Parkinson disease (PD) reported across MJH Life Sciences™.
A new study from Milliman investigated the potential financial impact if H.R.3, the Elijah E. Cummings Lower Drug Costs Now Act, was fully implemented.
Michael Thorpy, MD, director of the Sleep-Wake Disorders Center, Montefiore, and professor of neurology, Albert Einstein College of Medicine, discusses aspects of the Idiopathic Hypersomnia Severity Scale, and how it fared in measuring symptoms of idiopathic hypersomnia compared with traditional scales.
Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.
United States to buy and donate 500 million COVID-19 vaccine doses to the world; an FDA advisor resigns over a controversial Alzheimer drug approval; Nevada becomes the second state to offer state-managed health insurance plans.
Larry D. Anderson Jr, MD, PhD, associate professor, Harold C. Simmons Comprehensive Cancer Center, discusses updated findings of the phase II KarMMa trial assessing ide-cel chimeric antigen receptor (CAR) T-cell therapy for treatment of adult patients with relapsed or refractory multiple myeloma after 4 or more prior lines of therapy.
An initiative launched with the intent to deliver equitable cancer care improved the enrollment rates of Black participants in cancer clinical trials by focusing on community outreach and engagement.
Deep brain stimulation of the subthalamic nucleus was shown to remain effective in treating motor complications of people with Parkinson disease 15 years after initial surgery.
